Adrian Rabin
Lawyers
Filters
Revolution Medicines $750 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
ACELYRIN $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Labcorp $2 billion senior notes offering
The investment-grade notes are due 2030, 2032 and 2034
Terns Pharmaceuticals $173 million stock and pre-funded warrants offering
The shares are listed on the Nasdaq Global Select Market
Recursion Pharmaceuticals $230 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Sealed Air $400 million senior notes offering and concurrent tender offer
The new high-yield notes are due 2032
Applied Materials $700 million senior notes offering
The investment-grade notes are due 2029
Medtronic €3 billion notes offering
The notes are due 2029, 2036, 2043 and 2053
RxSight $115 million follow-on offering
The stock is listed on the Nasdaq Global Market
Oculis Holding $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market